Emerald Mutual Fund Advisers Trust’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Sell |
645,745
-78,609
| -11% | -$3.39M | 1.7% | 9 |
|
|
2025
Q1 | $25M | Sell |
724,354
-518
| -0.1% | -$17.9K | 1.78% | 10 |
|
|
2024
Q4 | $19.9M | Sell |
724,872
-26,483
| -4% | -$727K | 1.21% | 27 |
|
|
2024
Q3 | $19.1M | Buy |
751,355
+253,101
| +51% | +$6.44M | 0.99% | 36 |
|
|
2024
Q2 | $12.6M | Sell |
498,254
-2,000
| -0.4% | -$50.7K | 0.66% | 55 |
|
|
2024
Q1 | $15.5M | Hold |
500,254
| – | – | 0.81% | 48 |
|
|
2023
Q4 | $20.2M | Hold |
500,254
| – | – | 1.07% | 28 |
|
|
2023
Q3 | $13.2M | Buy |
500,254
+104,714
| +26% | +$2.76M | 0.8% | 55 |
|
|
2023
Q2 | $6.8M | Buy |
+395,540
| New | +$6.8M | 0.37% | 96 |
|